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1. Introduction 
The widespread presence of ester functionalities in fine 
chemicals, drug molecules, natural products, polymers and 
biodiesels means that acylation reactions of alcohols are one 
of the most widely used transformations in organic 
chemistry.1 Esters are also useful protecting groups that are 
widely used to protect acid and alcohol functionalities for 
the synthesis of complex natural products and drug 
molecules.2 Formyl esters are particularly useful in this 
regard, since they are acid stable and can be hydrolysed 
under mild basic conditions in the presence of other ester 
functionality.2b Simple esters are traditionally prepared using 
Fischer esterification procedures that involve azeotropic 
refluxing of an alcohol in the presence of an acid catalyst.1a 
More complex esters are normally prepared through reaction 
of an alcohol with an activated carboxylic acid derivative, 
such as an acyl halide, acid anhydride or activated acyl 
donor.3 However, O-acylation reactions of acyl chlorides and 
acid anhydrides are often exothermic,4 often generating 
acidic by-products that are incompatible with acid sensitive 
functionalities. Effective catalytic trans-esterification 
protocols have also been developed for ester formation, 
however these approaches often require use of excess or 
irreversible acyl donor to drive the O-acylation reaction to 
completion.5 Catalytic protocols involving Bronsted/Lewis 
acid catalysts, basic catalysts, metal complexes, enzymes 
and microwave irradiation conditions have been developed 
to increase the rate of O-acylation reactions under milder 
conditions.6 Formyl esters are prepared via in situ generation 
of reactive formylating species, or through the use of 
stoichiometric amounts of formylating agent.7 Although a 
wide range of O-acylation approaches are available,1 many 
of these methods suffer from practical disadvantages, or 
harsh reaction conditions, that give low yields of ester, as 
well as poor chemoselectivities and/or regioselectivities. that 
can cause purification problems, particularly on a large 
scale. Therefore, there is still a need to develop cheap 
reagents for the efficient O-acylation of alcohol substrates, 
particularly if their esterification reactions can be carried out 
under solvent and/or catalyst free conditions.8  
We have recently reported that formyloxyacetoxyphe-
nylmethane 1 (FAPM) can be used as a bench stable 
formylating agent for the conversion of primary and 
secondary amines into formamides 2 under solvent free 
conditions at room temperature (Scheme 1a).9a We have also 
shown that structurally related 1,1-diacylals 3 and mixed 1-
pivaloyl-1-acylals 4 can be used for the solvent free 
conversion of amines into their corresponding amides 5 
(Scheme 1b).9b A review of the literature revealed that 
ethylidene diacetate 6 had previously been reported to react 
with primary alcohols (1-butanol, 2-phenylethanol) in 
CHCl3 under acid catalysed conditions to afford their 
corresponding acetates 7 (no yields reported), acetaldehyde 
and acetic acid (Scheme 1c).10 Similarly, phenoxides have 
been used as nucleophiles to deprotect benzal diacetates 8 to 
afford their corresponding benzaldehydes, phenoxy acetate 9 
(no yield reported) and acetic acid as side products (Scheme 
1d).11a Catalytic amounts of tetrabutylammonium bromide 
have been used to catalyse the methanolysis of 1,1-acylals to 
afford their corresponding aldehydes in good yield.9b  
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Scheme 1 (a) Formyloxyacetoxyphenylmethane (FAPM) 1 
as an N-formylating agent for the synthesis of formamides 
2.9a (b) 1,1-diacylals 3 and mixed 1-pivaloxy-1-acyloxy-1-
phenylmethanes 4 as N-acylating agents for the synthesis of 
amides 5.9b (c) Ethylidene diacetate 6 as an O-acetylating 
agent for the synthesis of alkyl acetates 7.10 (d) Benzal 
diacetates 8 as an O-acetylating agent for the synthesis of 
phenoxy acetates 9.11 
Since the focus of these previous studies concentrated on 
using an alcohol as a nucleophile to deprotect acylals to 
afford their corresponding aldehydes, we decided to explore 
the scope and limitation of using FAPM 1 and 1,1-diacylals 
3/412 for the O-formylation and O-acylation reactions of 
alcohols. Consequently, we now report herein that these 
reagents may be used for the O-acylation of a range of 
primary and secondary alcohols under solvent/catalyst free 
conditions to give their corresponding formyl and acyl esters 
in good yield. 
2. Results and Discussion 
Our initial investigations focused on identifying conditions 
that would enable FAPM 1 to be used as a formylating agent 
for alcohols. Treatment of 2-(4-methoxyphenyl)ethanol 10a 
with 1.5 equiv. of FAPM 1 under solvent free conditions at 
rt for 24 h gave only 15% conversion to 4-
methoxyphenethyl formate 11a (Table 1, Entry 1), whilst 
repeating the reaction at 40 °C gave an improved 64% 
conversion (Table 1, Entry 2). Inclusion of EtOAc as a 
cosolvent at 40 °C had no effect on the extent of conversion 
(Table 1, Entry 3), however inclusion of 2 equiv. of 
NaHCO3 as a base resulted in improved results, affording 
72% and 91% conversion to formate ester 11a at rt (Table 1, 
Entry 4) and 40 °C (Table 1, Entry 5), respectively. Finally, 
repeating the formylation reaction using 1.5 equiv. of FAPM 
1 under solvent free conditions at 60 °C for 16 h resulted in 
complete consumption of 2-(4-methoxyphenyl)ethanol, 
enabling formate ester 11a to be isolated in 87% yield after 
chromatographic purification (Table1, Entry 6). There was 
no evidence of any competing acylation observed by 1H 
NMR during the course of the optimisation reactions. 
 
Table 1. Optimisation of the FAPM 1 mediated formylation 










1 None rt 24 None 15 
2 None 40 24 None 64 
3 EtOAc 40 24 None 66 












Conversion levels determined from integration of diagnostic resonances 
for 10a and 11a in the 1H NMR spectra of their crude reaction products. 
These optimal conditions were then applied for the O-
formylation of a range of primary, secondary and tertiary 
alcohols to produce twelve formate esters 11a-l in 60-88% 
yield (Scheme 2). Most of these O-formylation reactions 
were carried out by dissolving the alcohol substrates in 
FAPM 1 at 60 °C, addition of 2 equiv. of solid NaHCO3 
followed by stirring of the heterogeneous reaction mixture at 
60 °C for 16 h to afford a formyl ester that were then 
purified by chromatography. EtOAc was added as a co-
solvent when the parent alcohol was insoluble in FAPM 1, 
to afford a homogeneous solution, prior to addition of 
insoluble NaHCO3. Use of these basic reaction conditions 
afforded alkyl formates 11a-b, benzylic formates 11c-d and 
allylic formates 11e-f in good 71-88% isolated yield. The 
ability of FAPM 1 to formylate p-methoxyphenol to afford 
reactive p-methoxyphenyl formate 11g in 75% isolated yield 
is noteworthy. FAPM 1 also showed good reactivity towards 
acyclic and cyclic secondary alcohols affording their 
corresponding formates 11h-j in 75-84% yield. Acid 
sensitive functional groups were also tolerated under these 
conditions, as demonstrated for the synthesis of O-silyl-O-
formate ester 11k and acetonide-O-formate ester 11l in 60% 
and 87% yields, respectively.  
Our attention then turned to investigating the potential of 
employing less reactive 1,1-acylal 3a for the O-acetylation of 
alcohols. Use of our previously established base catalyzed O-
formylation conditions (60 °C, 2 equiv. NaHCO3, 16 h) for the 
acetylation of benzyl alcohol with 1,1-diacylal 3a were only 
partially successful, affording its corresponding acetate 12a in 
only 80% conversion after 16 h. However, a brief optimization 
study revealed that treatment of benzyl alcohol with 1.5 equiv. 
of 1,1-diacylal 3a and 2 equivalents of K2CO3 at 90 °C for 16 h 




(a) 1.5 equiv. FAPM 1, 2 equiv. NaHCO3, 16 h, 60 °C. (b) 1.5 
equiv. FAPM 1, 2 equiv. NaHCO3, EtOAc, 16 h, 60 °C.  
Scheme 2 FAPM 1 as an O-formylating agent for the 
synthesis of formate esters 11a-l. 
These optimal conditions were then applied for the 
esterification of a range of thirteen primary and secondary 
alcohols which gave their corresponding acetates 12a-m in 63-
92% isolated yields (Scheme 3). A wide range of different 
alcohol substrates were successfully O-acetylated to afford 
alkyl acetates 12a-c, benzylic acetate 12d, pyridyl acetate 12e 
and allylic acetates 12f-h in 68-92% yield. 1,1-Diacylal 3a also 
showed good reactivity towards acyclic and cyclic secondary 
alcohols affording their corresponding acetates 12i-k in 68-77% 
yield. Finally, use of 3 equivalents of 1,1-diacylal 3a resulted in 
bis-acetylation of the diol fragment of methyl 4,6-O-
benzylidene-α-D-glucopyran-oside to afford bis-acetate 12l in 
65% yield. Similarly, use of 6 equiv. of 1,1-diacylal 3a, resulted 
in the tetra-acetylation of the tetrol fragment of methyl α-
glucopyranoside to afford tetra-acetate 12m in 63% isolated 
yield. 
A range of 1,1-diacylal reagents 3b-g were then used for the 
O-acylation of benzyl alcohol at 90 °C for 16 h under solvent 
free conditions to give five esters 13a-e containing propionyl, 
benzoyl, hexanoyl, phenylacetoyl and acryloyl groups in 62-
94% yields, respectively (Scheme 4). The trifluoro-1,1-diacylal 
reagent 3g proved to more reactive, with trifluoroacetylation of 
benzyl alcohol proceeding at rt after only 1 h to afford 






(a) 1.5 equiv. acylal 3a, 2.0 equiv. K2CO3, 16 h, 90 °C. (b) 
1.5 equiv. acylal 3a, 2.0 equiv. K2CO3, 24 h, 90 °C. (c) 3 
equiv. acylal 3a, 2.0 equiv. K2CO3, 16 h, 90 °C. (d) 6.0 
equiv. acylal 3a, 8.0 equiv. K2CO3, 16 h, 90 °C. (*) Toluene 
(2 mL) added. (+) Water (2 mL added) 
Scheme 3 1,1-Diacylal 3a as an O-acylating agent for the 
synthesis of acetates 12a-m.  
 
a) 1.5 equiv. 1,1-diacylal 3a-f, 2.0 equiv. K2CO3, 90 °C, 16 
h. (b) 1.5 equiv. 1,1-diacylal 3g, 2.0 equiv. K2CO3, rt, 1 h. 
Scheme 4 Symmetric 1,1-diacylals 3b-g as O-acylating 
agents of benzyl alcohol for the synthesis of benzyl esters 
13a-f. 
Tetrahedron 4 
Following on from our previous success of using 1-
pivaloxy-1-acyloxy-1-phenylmethanes for the N-acylation of 
amines (Scheme 1b),9b we next decided to investigate 
whether mixed 1-pivaloxy-1-acyloxy-1-phenylmethanes 4 
could be used as selective O-acyl donors for alcohols. This 
would avoid wastage of one equivalent of a valuable 
acylating group that occurs when symmetric 1,1-acylals 3a-
g are used for O-acylating reagents. These mixed 1,1-
diacylal reagents were prepared by treatment of 
benzaldehyde with 1.5 equiv. of pivaloyl chloride and a 
catalytic amount of pTSA to afford chloro(phenyl)methyl 
pivalate 14,13 that was then reacted immediately with a 
series of carboxylic acids and Et3N in acetone at 40 °C to 
afford five mixed 1-pivaloxy-1-acyloxy-1-phenylmethanes 
4a-e in 74-84% yield (Scheme 5).9b 
 
Scheme 5. Synthesis of mixed 1-pivaloxy-1-acyloxy-1-
phenylmethanes 4a-e. 
These 1-pivaloxy-1-acyloxy-1-phenylmethanes 4a-e were 
then used as O-acylating reagents for a range of primary 
alkyl and allylic alcohols to give 10 primary esters (12a, 
13a, 13c, 13e, 13g-l) in 62-96% yield (Scheme 6). Selective 
O-acyl transfer (acetyl, phenylacetyl, propionyl, acryloyl 
and furanoyl) was observed for all the mixed 1,1-diacylals 
4a-e employed, with no evidence of any competing O-
pivaloyl transfer having occurred in any of these O-acylation 
reactions.  
The N-/O- selectivity profiles of the acylating agent 3a and 
formylating agent 1 was then investigated using L-serine 
methyl ester (S)-15 as a bifunctional substrate. N-acetylation 
of (S)-15 was performed using 1.5 equiv. of 1,1-diacylal 3a 
under neutral conditions (70 °C, 16 h)9a to selectively afford 
N-acetyl-L-serine methyl ester (S)-16 ([α]D
25 = -9.5; Lit14a = -
10.1) as a single product in 83% yield (Scheme 7).14 O-
formylation of the free hydroxyl group of (S)-16 was then 
carried out using 1.5 equiv. of FAPM 1, using our standard 
basic conditions (2 equiv. NaHCO3, 60 °C, 16 h, to afford N-
acetyl-O-formyl-L-serine methyl ester (S)-17 ([α]D
20 = -56.0) 
in 78% yield. We initially considered that competing base 
mediated N-/O-acetyl migration to afford O-acetyl-L-serine 
methyl ester might have occurred, followed by N-
formylation to afford (S)-N-formyl-O-acetyl-serine methyl 
ester 18 as an alternative product. However, analysis of the 
13C NMR spectrum of the formylation product revealed 
resonances at  170.0, 169.9 and 160.3, consistent with the 
presence of the ester, amide and formyl ester groups of (S)-
17.9 This is in contrast to the 13C NMR chemical shifts for 
the methyl esters and formamide groups of (S)-18, that 
would be expected to appear in the  169-174 region of its 
13C NMR spectrum.9 
 
(*) Toluene (2 mL) added 
Scheme 6. O-acylation reactions of 1-pivaloxy-1-acyloxy-1-
phenylmethanes 4a-e to afford esters 12a, 13a, 13c, 13e, 
13g-l 
 
Scheme 7. Synthesis of N-acetyl-O-formyl-L-serine methyl 
ester (S)-17. 
3. Conclusions 
In summary, we have shown that formyloxyacetoxyphenyl-
methane 1 and 1,1-diacylals 3 can be used as moisture-
tolerant O-acylating reagents for primary and secondary 
alcohols under solvent-free conditions to afford their 
corresponding esters in good yields. This O-acylation 
methodology has been extended to enable mixed pivaloyl 
1,1-acylals 4 to be used as efficient O-acylating agents for 
the selective transfer of a range of acyl donor groups to a 
wide range of alcohols. We have also demonstrated the 
inherent N-/O- selectivity of these acylal acylating reagents 
for the selective N-acetylation of serine methyl ester 
followed by O-formylation of its primary alcohol group to 
selectively afford orthogonally protected N-acetyl-O-formyl 







Unless preparative details are given, reagents and solvents 
were obtained from commercial suppliers. All reactions 
were performed without air exclusion, at room temperature 
with magnetic stirring unless otherwise stated. Anhydrous 
MgSO4 or Na2SO4 were used as drying agents for organic 
solutions. Petrol refers to petroleum ether with a boiling 
range of 40-60 °C. Thin layer chromatography (TLC) was 
carried out using Macherey-Nagel aluminium-backed plates, 
precoated with silica. Compounds were visualised by 
quenching of UV fluorescence at 254 nm or, where 
necessary, by staining with potassium permanganate, 
phosphomolybdic acid (PMA) or vanillin dip, followed by 
gentle heating. Purification by flash column chromatography 
was performed using high-purity grade 60 Å silica gel (60 Å 
pore size, 40-75 μm particle size). Capillary melting points 
were determined using a Stuart digital SMP10 melting point 
apparatus and are reported to the nearest °C. An Optical 
Activity Ltd AA-10 Series Automatic Polarimeter with a 
path length of 1 dm was used to measure optical rotations, 
with concentration (c) quoted in g/100 mL. Nuclear 
Magnetic Resonance (NMR) spectroscopy experiments were 
performed in deuterated solvent at 298 K on either a Brüker 
Avance 250, 300, 400 or 500 MHz spectrometer or an 
Agilent ProPulse 500 MHz spectrometer, with proton 
decoupling for all 13C NMR spectra. 1H and 13C NMR 
chemical shifts, δ, are quoted in parts per million (ppm) and 
referenced against the residual, non-deuterated solvent peak. 
Ratios of formamide rotamers were determined by 
comparison of the integrals for equivalent peaks in their 1H 
NMR spectra. A PerkinElmer Spectrum 100 FTIR 
spectrometer with Universal ATR FTIR accessory was used 
to record infrared (IR) spectra; with samples run neat and 
the most relevant, characteristic absorbances quoted as ν in 
cm-1. High resolution mass spectrometry (HRMS) results 
were acquired on an externally calibrated Bruker Daltonics 
micrOTOFTM time-of-flight mass spectrometer coupled to an 
electrospray source (ESI-TOF). Molecular ions were 
detected in positive mode as either the protonated or 
sodiated form, with Bruker Daltonics software, 
DataAnalysisTM used to process the data. 
(Formyloxy)(phenyl)methyl acetate 1 and 
phenylmethylene diacetate were prepared using our 
previously described protocols.9 
 
General Procedure A: O-formylation of alcohols 
Alcohol (1.0 mmol) was added to 
(formyloxy)(phenyl)methyl acetate 1 (0.291 g, 1.5 mmol) 
and NaHCO3 (0.168 g, 2.0 mmol), and the reaction stirred at 
60 °C for 16 h. EtOAc (2mL) was added as a cosolvent 
when the alcohol substrate was insoluble in the fomylating 
reagent at 60 °C. The crude reaction mixture was then 
purified by column chromatography to give the desired 
formate ester.  
 
General Procedure B: O-Acetylation of alcohols 
Alcohol (1.0 mmol) was added to phenylmethylene diacetate 
3a (0.291 g, 1.5 mmol) and K2CO3 (0.270 g, 2.0 mmol) and 
the reaction stirred at 90 °C for 16 or 24h. Toluene or 
DMSO (2 mL) was added as a cosolvent when the alcohol 
substrate was insoluble in the formylating reagent at 60 °C. 
The crude reaction mixture was then purified by column 
chromatography to give the isolated ester.  
General Procedure C: Synthesis of 1,1-diacylals 
para-Toluenesulphonic acid (mono hydrate) (0.18 g, 0.94 
mmol) was added to a mixture of benzaldehyde (1.0 g, 9.4 
mmol) and anhydride (18.8 mmol) at rt. The reaction was 
stirred for 12 h and then diluted with Et2O (50 mL) and 
washed with saturated Na2CO3 (3 x 20 mL). The organics 
were dried (MgSO4) and concentrated in vacuo to give the 
title compound which was used in subsequent steps without 
further purification unless otherwise stated. 
 
General Procedure D: O-acylation of alcohols 
Alcohol (1.0 mmol) was added to the acylation reagent (1.5 
mmol) and K2CO3 (0.270 g, 2.0 mmol). Toluene (2 mL) was 
added as a cosolvent when the alcohol substrate was 
insoluble in the formylating reagent at 60 °C. The reaction 
was then stirred at 90 °C for 16 or 24h. The crude reaction 
mixture was then purified by column chromatography to 
give the isolated ester. 
 
General Procedure E: Synthesis of mixed acylals 
Trimethylacetyl chloride (0.813 mL, 6.60 mmol) was added 
dropwise to a mixture of benzaldehyde (0.489 g, 4.40 mmol) 
and p-toluenesulfonic acid (0.083 g, 0.44 mmol) at rt and the 
reaction mixture stirred for 3 h. The reaction was then 
quenched via addition of saturated NaHCO3 (10 mL) and 
diluted with Et2O (50 mL). The reaction was then extracted 
with saturated NaHCO3(aq) (3 x 20 mL), the organic layer 
dried (MgSO4) and concentrated in vacuo to afford 
chloro(phenyl)methyl pivalate 14 (1.0 g, 4.40 mmol) as a 
yellow oil that was carried forward to the next step without 
further purification. Triethylamine (0.60 mL, 4.40 mmol) 
was added dropwise to a solution of chloro(phenyl)methyl 
pivalate 14 (4.40 mmol) and carboxylic acid (4.40 mmol) in 
acetone (10 mL). The reaction was stirred at 40 °C for 12 h, 
over which time a white ppt formed. The reaction mixture 
was filtered through Celite® and concentrated in vacuo to 
afford a crude reaction product that was purified by silica 
gel chromatography to give the desired mixed acylal. 
 
4-Methoxy phenethyl alcohol formate 11a 
General procedure A was followed to afford the title 
compound (0.127 g, 0.71 mmol) as a clear oil in 71% yield. 
1H NMR (300 MHz, CDCl3) δ 8.05 (s, 1H, (C=O)H), 7.19 - 
7.10 (m, 2H, ArH), 6.91 - 6.81 (m, 2H, ArH), 4.36 (t, J = 7.0 
Hz, 2H, CH2(OC=O)), 3.81 (s, 3H, CH3), 2.93 (t, J = 7.2 Hz, 
2H, CH2CH2(OC=O)). 
13C NMR (75 MHz, CDCl3) δ 161.0, 
158.4, 129.8, 129.3, 113.9, 64.6, 55.2, 34.0. 
Analytical data in accordance with the literature.7h 
 
Citronellyl formate 11b 
General procedure A was followed to afford the title 
compound (0.153 g, 0.83 mmol) as a clear oil in 83% yield. 
1H NMR (300 MHz, CDCl3) δ 8.06 (s, 1H, (C=O)H), 5.19 - 
4.98 (m, 1H, C=CH), 4.29 - 4.11 (m, 2H, CH2O(C=O)H), 
Tetrahedron 6 
2.12 - 1.83 (m, 2H,), 1.81 - 1.64 (m, 4H), 1.61 (s, 3H, 
C=CCH3), 1.58 - 1.29 (m, 3H), 1.27 - 1.14 (m, 1H), 0.93 (d, 
J = 6.4 Hz, 3H, CHCH3). 
13C NMR (75 MHz, CDCl3) δ 
161.2, 131.4, 124.5, 62.5, 36.9, 35.3, 29.4, 25.7, 25.4, 19.3, 
17.6. 
Analytical data in accordance with the literature.7h 
 
2-Bromobenzyl alcohol formate 11c 
General procedure A was followed to afford the title 
compound (0.172 g, 0.80 mmol) as a yellow oil in 80% 
yield. 1H NMR (500 MHz, CDCl3) δ 8.19 (s, 1H, (C=O)H), 
7.61 (dd, J = 1.2, 8.1 Hz, 1H, ArH), 7.45 (dd, J = 2.0, 7.8 
Hz, 1H, ArH), 7.34 (dt, J = 1.2, 7.5 Hz, 1H, ArH), 7.25 - 
7.20 (m, 1H, ArH), 5.31 (s, 2H, CH2). 
13C NMR (126 MHz, 
CDCl3) δ 160.5, 134.5, 132.9, 130.1, 130.0, 127.6, 123.5, 
65.2. IR (thin film) ν max (cm-1): 1719 (C=O);.14 
 
Biphenyl-4-methanol formate 11d 
General procedure A was followed to afford the title 
compound (0.170 g, 0.80 mmol) as a crystalline white solid 
in 80% yield. 1H NMR (300 MHz, CDCl3) δ = 8.18 (t, J = 
0.9 Hz, 1H, (C=O)H), 7.65 - 7.57 (m, 4H, ArH), 7.50 - 7.42 
(m, 4H, ArH), 7.41 - 7.34 (m, 1H, ArH), 5.27 (s, 2H, 
CH2O(C=O)). 
13C NMR (75 MHz, CDCl3) δ 160.8, 141.5, 
140.5, 134.1, 128.9, 128.8, 127.5, 127.4, 127.1, 65.5. IR 
(thin film) ν max (cm-1): 1702 (C=O);15 
 
Perillyl alcohol formate 11e 
General procedure A was followed to afford the title 
compound (0.159 g, 0.88 mmol) as a yellow oil in 88% 
yield. [α]D
20 = -62.5 in MeOH. 1H NMR (300 MHz, CDCl3) 
δ 8.11 (s, 1H, (C=O)H), 5.86 - 5.76 (m, 1H, CH2C=CH), 
4.77 - 4.70 (m, 2H, C=CH2), 4.57 (s, 2H, CH2O(C=O)), 2.26 
- 2.06 (m, 4H, CH2), 2.05 - 1.94 (m, 1H, CH), 1.93 - 1.80 
(m, 1H, CH), 1.75 (s, 3H, CH3), 1.60 - 1.41 (m, 1H, CH). 
13C NMR (75 MHz, CDCl3) δ 161.0, 149.4, 132.0, 126.8, 
108.8, 68.0, 40.7, 30.4, 27.2, 26.3, 20.7. IR (thin film) ν max 
(cm-1): 1722 (C=O); HRMS (ESI): m/z calculated for 
C11H16O2: requires: 181.1228 for [M+H]
+; found: 181.1210. 
 
Geranyl formate 11f 
General procedure A was followed to afford the title 
compound to give the title compound (0.155 g, 0.85 mmol) 
as a pale yellow oil in 85% yield. 1H NMR (300 MHz, 
CDCl3) δ 8.08 (s, 1H, (C=O)H), 5.45 - 5.31 (m, 1H 
C=CHCH2O), 5.20 - 5.00 (m, 1H, C=CHCH2), 4.70 (d, J = 
7.2 Hz, 2H, CH2O(C=O)), 2.17-2.06 (m, 4H, CH2CH2), 1.76 
- 1.71 (m, 3H CH3C(CH3)=CH), 1.71 - 1.67 (m, 3H, 
CH3C(CH3)=CH), 1.61 (s, 3H, CH2C(CH3)=CH). 
13C NMR 
(75 MHz, CDCl3) δ 161.1, 143.2, 131.9, 123.6, 117.6, 60.8, 
39.5, 26.2, 25.7, 17.7, 16.5. Analytical data in accordance 
with literature.16 
 
4-Methoxyphenol formate 11g 
General procedure A was followed to afford the title 
compound (0.114 g, 0.75 mmol) as an orange oil in 75% 
yield. 1H NMR (300MHz, CDCl3) δ 8.30 (s, 1H, (C=O)H), 
7.12 - 7.01 (m, 2H, ArH), 6.96 - 6.87 (m, 2H, ArH), 3.82 (s, 
3H, CH3). 
13C NMR (75MHz, CDCl3) δ 159.7, 157.6, 143.3, 
122.0, 114.6, 55.0. Analytical data in accordance with 
literature.17  
 
1-Phenylethanol formate 11h 
General procedure A was followed to afford the title 
compound (0.112 g, 0.75 mmol) as a pale yellow oil in 75% 
yield. 1H NMR (300 MHz, CDCl3) δ 8.11 (s, 1H, (C=O)H), 
7.42 - 7.28 (m, 5H, ArH), 6.18 - 5.85 (m, 1H, CH(OC=O)), 
1.60 (d, J = 7.2 Hz, 3H, CH3). 
13C NMR (75MHz, CDCl3) δ 
160.4, 140.8, 128.6, 128.1, 126.1, 72.2, 22.1. Analytical data 
in accordance with the literature.7h 
 
Menthol formate 11i 
General procedure A was followed to afford the title 
compound (0.143 g, 0.78 mmol) as a yellow oil in 78% 
yield. 1H NMR (300 MHz, CDCl3) δ 8.08 (d, J = 0.8 Hz, 1H, 
(C=O)H), 4.81 (dt, J = 4.3, 10.8 Hz, 1H, CH(OC=O)), 2.07 - 
1.97 (m, 1H, CH), 1.91 (dtd, J = 2.6, 7.0, 13.9 Hz, 1H, CH), 
1.76 - 1.64 (m, 2H, CH2), 1.59 - 1.33 (m, 2H, CH2), 1.14 - 
0.98 (m, 2H, CH), 0.95 - 0.84 (m, 7H, CH & CH(CH3)2), 
0.77 (d, J = 6.8 Hz, 3H, CH3). 
13C NMR (75 MHz, CDCl3) δ 
160.9, 74.1, 46.8, 40.8, 34.1, 31.4, 26.0, 23.2, 22.0, 20.7, 
16.0. Analytical data in accordance with the literature.7a  
 
Carveol formate 11j 
General procedure A was followed to afford the title 
compound as a yellow oil (0.150 g, 0.84 mmol) in 84% 
yield. The formate ester was obtained as a mixture of 
diastereomers (1:1) in the same ratio as the starting material. 
1H NMR (300 MHz, CDCl3) δ 8.17 (d, J = 1.1 Hz, 1H, 
(C=O)H), 8.14 (s, 1H, (C=O)H), 5.82 - 5.75 (m, 1H), 5.68 - 
5.53 (m, 2H), 5.44 - 5.37 (m, 1H), 4.78 - 4.74 (m, 2H), 4.74 
- 4.70 (m, 2H), 2.40 - 2.06 (m, 5H), 2.04 - 1.82 (m, 4H), 
1.76 - 1.68 (m, 10H), 1.68 - 1.63 (m, 3H), 1.61 - 1.56 (m, 
1H). 13C NMR (75 MHz, CDCl3) δ 161.1 (α), 161.0 (β), 
148.5 (α), 148.1 (β), 132.1 (α), 130.2 (β), 128.6 (α), 126.5 
(β), 109.5 (α), 109.4 (β), 73.1 (α), 70.5 (β), 40.2 (α), 35.7 
(β), 33.9 (α), 33.7 (β), 30.8 (α), 30.7 (β), 20.8 (α), 20.5 (β), 
20.5 (α), 18.8 (β). IR (thin film) ν max (cm-1): 1717 (C=O); 
HRMS (ESI): m/z calculated for C11H16O2: requires: 
181.1228for [M+H]+; found: 181.1190. 
 
4-((tert-butyldimethylsilyl)oxy)butan-2-yl formate 11k 
General procedure A was followed to afford the title 
compound (0.140 g, 0.60 mmol) as a yellow oil in 60% 
yield. 1H NMR (500 MHz, CDCl3) δ 8.04 (s, 1H, C(O)H), 
5.20 – 5.12 (m, 1H, CHOC(O)H), 3.70 – 3.62 (m, 2H, 
CH2OSiTBDMS), 1.84 (ddt, J = 13.6, 8.1, 5.5 Hz, 1H, 
CHaCHbCH2OSiTBDMS), 1.79 – 1.71 (m, 1H, 
CHaCHbCH2OSiTBDMS), 1.30 (d, J = 6.4 Hz, 3H, CH3CH), 
0.88 (s, 9H, Si(CH3)2C(CH3)3), 0.04 (s, 6H, 
Si(CH3)2C(CH3)3). 
13C NMR (126 MHz, CDCl3) δ 160.9, 
68.7, 59.3, 38.9, 26.0, 20.4, 18.4, -5.27, -5.29. IR (thin film) 
ν max (cm-1): 1725 (C=O); HRMS (ESI): m/z calculated for 




(2,2-dimethyl-1,3-dioxolan-4-yl)methyl formate 11l 
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General procedure A was followed to afford the title 
compound (0.139 g, 0.87 mmol) as a yellow oil in 87% 
yield. 1H NMR (500 MHz, CDCl3) δ 8.09 (s, 1H, C(O)H), 
4.35 (qd, J = 6.2, 4.6 Hz, 1H, CH2CHCH2OC(O)), 4.26 
(ddd, J = 11.5, 4.6, 0.9 Hz, 1H, CH2CHCHaHbOC(O)), 4.17 
(ddd, J = 11.5, 6.2, 0.8 Hz, 1H, CH2CHCHaHbOC(O)), 4.10 
(dd, J = 8.5, 6.5 Hz, 1H, CHaCHbCHCH2OC(O)), 3.76 (dd, J 
= 8.6, 6.0 Hz, 1H, CHaCHbCHCH2OC(O)), 1.44 (s, 3H, 
CH3), 1.37 (s, 3H, CH3). 
13C NMR (126 MHz, CDCl3) δ 
160.7, 110.2, 73.4, 66.4, 64.3, 26.8, 25.4. IR (thin film) ν 
max (cm-1): 1722 (C=O); HRMS (ESI): m/z calculated for 
C7H12O4: requires: 183.0628 for [M+Na]; found: 183.0631. 
 
Benzyl acetate 12a 
General procedure B was followed to afford the title 
compound (0.135 g, 0.90 mmol) as a clear oil in 90% yield.  
1H NMR (300 MHz, CDCl3) δ 7.48 – 7.29 (m, 5H, ArH), 
5.11 (s, 2H, CH2Ph), 2.11 (s, 3H, CH3). 
13C NMR (75 MHz, 
CDCl3) δ 171.1, 136.0, 128.7, 128.4, 66.5, 21.2. Analytical 
data in accordance with literature.18  
 
2-Bromophenethyl acetate 12b 
General procedure B was followed to afford the title 
compound (0.184 g, 0.76 mmol) as a clear oil in 76% yield. 
1H NMR (300 MHz, CDCl3) δ 7.55 (dt, J = 7.9, 0.9 Hz, 1H, 
ArH), 7.29 – 7.22 (m, 2H, ArH), 7.11 (ddd, J = 7.9, 5.1, 4.1 
Hz, 1H, ArH), 4.30 (t, J = 7.0 Hz, 2H, CH2OC(O)CH3), 3.09 
(t, J = 7.0 Hz, 2H, ArCH2), 2.04 (s, 3H, CH3). 
13C NMR (75 
MHz, CDCl3) δ 171.1, 137.3, 133.1, 131.2, 128.5, 127.6, 
124.8, 63.5, 35.4, 21.1. Analytical data in accordance with 
literature.19  
 
3,7-Dimethyloct-6-en-1-yl acetate 12c 
General procedure B was followed to afford the title 
compound (0.178 g, 0.90 mmol) as a clear oil in 92% yield. 
1H NMR (300 MHz, CDCl3) δ 5.08 (tdt, J = 5.8, 3.0, 1.5 Hz, 
1H, C=CH), 4.17 – 4.01 (m, 2H, CH2OAc), 2.04 (s, 3H, 
(C=O)CH3), 1.95 (dt, J = 15.0, 7.7 Hz, 2H, CH2), 1.72 – 
1.62 (m, 4H, CH2), 1.60 (d, J = 1.4 Hz, 3H,CH3(C)CH3), 
1.56 – 1.27 (m, 3H, CH3(C)CH3), 1.18 (dddd, J = 13.5, 9.1, 
7.5, 6.2 Hz, 1H, (CHCH3), 0.91 (d, J = 6.4 Hz, 3H, CHCH3). 
13C NMR (75 MHz, CDCl3) δ 171.4, 131.5, 124.7, 63.2, 
37.1, 35.5, 29.6, 25.9, 25.5, 21.2, 19.5, 17.8. Analytical data 
in accordance with literature.20  
 
[1,1'-biphenyl]-4-ylmethyl acetate 12d 
General procedure B was followed to afford the title 
compound (0.153 g, 0.68 mmol) as a white solid in 68% 
yield. 1H NMR (300 MHz, CDCl3) δ 7.63 – 7.55 (m, 4H, 
ArH), 7.49 – 7.41 (m, 4H, ArH), 7.40 – 7.32 (m, 1H, ArH), 
5.15 (s, 2H, CH2), 2.13 (s, 3H, CH3). 
13C NMR (75 MHz, 
CDCl3) δ 171.1, 141.4, 140.8, 135.0, 128.9, 127.6, 127.5, 
127.3, 66.2, 21.2. Analytical data in accordance with 
literature.21  
 
Pyridin-2-ylmethyl acetate 12e 
General procedure B was followed to afford the title 
compound (0.105 g, 0.70 mmol) as a clear oil in 70% yield. 
1H NMR (300 MHz, CDCl3) δ 8.60 (ddd, J = 4.9, 1.9, 0.9 
Hz, 1H, ArH), 7.70 (td, J = 7.7, 1.8 Hz, 1H, ArH), 7.35 (d, 
J = 7.8 Hz, 1H, ArH), 7.26 (s, 1H, ArH), 5.22 (s, 2H, CH2), 
2.16 (s, 3H, CH3). 
13C NMR (75 MHz, CDCl3) δ 170.8, 
155.8, 149.7, 136.9, 123.0, 122.0, 67.0, 21.1. Analytical data 
in accordance with literature.20  
 
Cinnamyl acetate 12f 
General procedure B was followed to afford the title 
compound (0.146 g, 0.83 mmol) as a clear oil in 83% yield. 
1H NMR (300 MHz, CDCl3) δ 7.26 (s, 5H, ArH), 6.66 (dt, J 
= 15.9, 1.4 Hz, 1H, CH=CHCH2), 6.29 (dt, J = 15.9, 6.5 Hz, 
1H, CH=CHCH2), 4.73 (dd, J = 6.5, 1.4 Hz, 2H, 
CH=CHCH2), 2.11 (s, 3H, CH3). 
13C NMR (75 MHz, 
CDCl3) δ 171.0, 136.3, 134.4, 128.7, 128.2, 126.7, 123.3, 
65.2, 21.2. Analytical data in accordance with literature.22  
 
(E)-3,7-dimethylocta-2,6-dien-1-yl acetate 12g 
General procedure B was followed to afford the title 
compound (0.174 g, 0.89 mmol) as a waxy white solid in 
89% yield.1H NMR (300 MHz, CDCl3) δ 5.34 (tq, J = 7.2, 
1.3 Hz, 1H, C=CHCH2O), 5.08 (tq, J = 5.5, 1.5 Hz, 1H, 
C=CHCH2), 4.58 (d, J = 7.1 Hz, 2H, CH2OAc), 2.16 – 1.99 
(m, 7H, 2 x CH2 and (C=O)CH3), 1.69 (dd, J = 5.9, 1.3 Hz, 
6H, CH3(C)CH3), 1.60 (d, J = 1.4 Hz, 3H, CH2C(CH3)=CH). 
13C NMR (75 MHz, CDCl3) δ 171.3, 142.5, 132.0, 123.9, 
118.3, 61.6, 39.7, 26.4, 25.8, 21.2, 17.8, 16.6. Analytical 
data in accordance with literature.20  
 
(S)-(4-(prop-1-en-2-yl)cyclohex-1-en-1-yl)methyl acetate 12h 
General procedure B was followed to afford the title 
compound as a clear oil in 85% yield (0.165 g, 0.85 mmol). 
[α]D
20 = -65.5 in CHCl3. 
1H NMR (300 MHz, CDCl3) δ 5.76 
(dd, J = 4.6, 2.4 Hz, 1H, CH2C=CH), 4.80 – 4.66 (m, 2H, 
C=CH2), 4.45 (d, J = 1.7 Hz, 2H, CH2OAc), 2.23 – 2.04 (m, 
7H, 2 x CH2 and (C=O)CH3), 2.03 – 1.80 (m, 2H, CH2), 1.74 
(t, J = 1.1 Hz, 3H, CH3C=CH2), 1.54 – 1.41 (m, 1H, CH). 
13C NMR (75 MHz, CDCl3) δ 171.2, 149.8, 132.7, 126.0, 
108.9, 68.7, 40.9, 30.6, 27.4, 26.5, 21.2, 20.9. Analytical 
data in accordance with literature.23  
 
(rac)-1-phenylethyl acetate 12i 
General procedure B was followed to afford the title 
compound (0.126 g, 0.77 mmol) as a pale yellow oil in 77% 
yield. 1H NMR (300 MHz, CDCl3) δ 7.40 – 7.26 (m, 5H, 
ArH), 5.88 (q, J = 6.6 Hz, 1H, CH), 2.08 (s, 3H, C(O)CH3), 
1.54 (d, J = 6.6 Hz, 3H, CHCH3). 
13C NMR (75 MHz, 
CDCl3) δ 170.5, 141.8, 128.6, 128.0, 126.2, 72.5, 22.4, 21.5. 
Analytical data in accordance with literature.24  
 
2-Methyl-5-(prop-1-en-2-yl)cyclohex-2-en-1-yl acetate (mix of 
isomers) 12j 
General procedure B was followed to afford the title 
compound (0.132 g, 0.68 mmol) as a clear oil in 68% yield. 
1H NMR (300 MHz, CDCl3) δ 5.74 (dt, J = 5.3, 1.8 Hz, 1H), 
5.60 (dq, J = 5.5, 1.8 Hz, 1H), 5.45 (d, J = 1.5 Hz, 1H), 5.30 
– 5.22 (m, 1H), 4.77 – 4.68 (m, 4H), 2.37 – 2.15 (m, 4H), 
2.08 (d, J = 1.0 Hz, 6H), 2.02 – 1.79 (m, 3H), 1.72 (dt, J = 
4.4, 1.1 Hz, 5H), 1.69 (dd, J = 2.7, 1.4 Hz, 3H), 1.64 (dp, J = 
2.5, 1.3 Hz, 3H), 1.61 – 1.54 (m, 1H), 1.53 – 1.41 (m, 1H). 
Tetrahedron 8 
13C NMR (75 MHz, CDCl3) δ 171.1, 171.1, 148.9, 148.4, 
133.0, 131.1, 128.1, 126.1, 109.5, 109.3, 73.4, 70.8, 40.4, 
35.9, 34.1, 33.7, 31.0, 30.9, 21.6, 21.4, 21.0, 20.8, 20.6, 




dimethyltetrahydrofuro[2,3-d][1,3]dioxol-6-yl acetate 12k 
General procedure B was followed for 24 h to afford the title 
compound (0.21 g, 0.69 mmol) as a white solid in 70% 
yield. [α]D
20 = -32 in CHCl3. 
1H NMR (300 MHz, CDCl3) δ 
5.88 (d, J = 3.7 Hz, 1H, OCHO), 5.24 (d, J = 2.4 Hz, 1H, 
OCHCHOC(O)CH3), 4.50 (d, J = 3.7 Hz, 1H, 
OCHC(O)CH2), 4.25 – 4.17 (m, 2H, 
OCH(CHOCH2O)C(O)CH3 and CHC(O)CH3), 4.05 (tdd, J = 
10.7, 7.0, 3.3 Hz, 2H, OCH2CHO), 2.10 (s, 3H, 
CHC(O)CH3), 1.52 (s, 3H, OCO(CH3aCH3b)), 1.41 (s, 3H, 
OCO(CH3aCH3b)), 1.32 (s, 3H, OCO(CH3aCH3b)), 1.30 (s, 
3H, OCO(CH3aCH3b)). 
13C NMR (75 MHz, CDCl3) δ 169.8, 
112.4, 109.5, 105.1, 83.4, 79.8, 76.3, 72.5, 67.3, 27.0, 26.8, 








g, 1.0 mmol) was added to phenylmethylene diacetate (0.582 
g, 3.0 mmol) and K2CO3 (0.270 g, 2.0 mmol) and the 
reaction mixture stirred at 90 °C for 16 h. The crude reaction 
mixture was then purified by column chromatography to 
give the title compound (0.238 g, 0.65 mmol) as a white 
solid in 65% yield. 1H NMR (300 MHz, CDCl3) δ 7.44 (qd, 
J = 5.4, 4.5, 1.9 Hz, 2H, ArH), 7.36 (dt, J = 4.6, 2.8 Hz, 3H, 
ArH), 5.58 (t, J = 9.6 Hz, 1H, CHOCH3), 5.51 (s, 1H, 
PhCH), 4.95 – 4.88 (m, 2H, 2 x CHC(O)CH3), 4.31 (dd, J = 
10.1, 4.7 Hz, 1H, CH2CH(O)CH(O)), 3.93 (td, J = 9.9, 4.7 
Hz, 1H, CH2CH(O)CH(O)), 3.77 (t, J = 10.2 Hz, 1H, 
OCHaHbCHO), 3.65 (t, J = 9.6 Hz, 1H, OCHaHbCHO), 3.41 
(s, 3H, OCH3), 2.10 (s, 3H, C(O)CH3), 2.05 (s, 3H, 
C(O)CH3). 
13C NMR (75 MHz, CDCl3) δ 170.6, 169.9, 
137.0, 129.2, 128.4, 126.3, 101.7, 97.7, 79.3, 71.7, 69.1, 
69.0, 62.4, 55.5, 21.0, 20.9. Analytical data in accordance 
with literature.27  
 
(2R,3S,4R,5S,6S)-2-(acetoxymethyl)-6-methoxytetrahydro-
2H-pyran-3,4,5-triyl triacetate 12m 
Methyl α-D-glucopyranoside (0.194 g, 1.0 mmol) was added 
to phenylmethylene diacetate (1.16 g, 6.0 mmol) and K2CO3 
(1.10 g, 8.0 mmol) the reaction was stirred at 90 °C for 16 h. 
The crude reaction mixture was then purified by column 
chromatography to give the title compound (0.230 g, 0.63 
mmol) as a white solid in 63% yield. 1H NMR (300 MHz, 
CDCl3) δ 5.48 (dd, J = 10.1, 9.4 Hz, 1H), 5.07 (dd, J = 10.2, 
9.3 Hz, 1H), 4.98 – 4.84 (m, 2H), 4.26 (dd, J = 12.3, 4.6 Hz, 
1H), 4.10 (dd, J = 12.3, 2.4 Hz, 1H), 3.98 (ddd, J = 10.2, 
4.6, 2.3 Hz, 1H), 3.41 (s, 3H), 2.10 (s, 3H), 2.08 (s, 3H), 
2.03 (s, 3H), 2.01 (s, 3H). 13C NMR (75 MHz, CDCl3) δ 
170.9, 170.3, 170.3, 169.8, 96.9, 70.9, 70.2, 68.6, 67.2, 62.0, 
55.6, 20.90, 20.85, 20.8. Analytical data in accordance with 
literature.8d  
 
Phenylmethylene dipropionate 3b 
General procedure C was followed to afford the title 
compound (2.15 g, 9.12 mmol) as a clear oil in 97% yield.1H 
NMR (300 MHz, CDCl3) δ 7.71 (s, 1H, CH(OCOEt)2), 7.51 
(qd, J = 3.8, 1.5 Hz, 2H, ArH), 7.41 (ddt, J = 4.3, 3.1, 1.6 
Hz, 3H, ArH), 2.40 (tt, J = 7.4, 3.6 Hz, 4H, 2 x CH2CH3), 
1.16 (t, J = 7.5 Hz, 6H, 2 x CH2CH3). 
13C NMR (75 MHz, 
CDCl3) δ 172.47, 135.81, 129.80, 128.72, 126.78, 89.72, 
27.55, 8.89. IR (thin film) ν max (cm-1): 2983 (ArC-H), 
1756 (C=O); HRMS (ESI): m/z calculated for C13H12O4: 
requires: 259.0946 for [M+Na]+; found: 259.0995. 
Analytical data in accordance with literature.28 
 
Phenylmethylene dibenzoate 3c 
General procedure C was followed to afford the title 
compound (3.09 g, 9.30 mmol) as a clear oil in 99% yield. 
1H NMR (300 MHz, CDCl3) δ 8.25 – 8.06 (m, 5H, CH and 
ArH), 7.75 – 7.64 (m, 3H, ArH), 7.62 – 7.50 (m, 4H, ArH), 
7.49 – 7.40 (m, 4H, ArH). 13C NMR (75 MHz, CDCl3) δ 
164.6, 162.5, 134.7, 133.7, 130.7, 130.2, 129.9, 129.2, 
129.0, 128.9, 128.6, 126.9, 90.8. IR (thin film) ν max (cm-1): 
3064 (ArC-H), 1722 (C=O); HRMS (ESI): m/z calculated 
for C21H16O4: requires: 355.0946 for [M+Na]
+; found: 
355.0929. Analytical data in accordance with literature.28 
 
Phenylmethylene diacrylate 3d 
General procedure C was followed to afford the title 
compound (2.12 g, 9.12 mmol) as a clear oil in 97% yield. 
1H NMR (300 MHz, CDCl3) δ 7.87 (s, 1H, CHPh), 7.65 – 
7.48 (m, 2H, ArH), 7.51 – 7.36 (m, 3H, ArH), 6.52 (dd, J = 
17.3, 1.4 Hz, 2H, CHaHb=CH), 6.27 – 6.03 (m, 2H, 
CHaHb=CH), 5.93 (dd, J = 10.5, 1.3 Hz, 2H, CHaHb=CH). 
13C NMR (75 MHz, CDCl3) δ 164.0, 134.8, 132.8, 129.9, 
128.8, 127.6, 126.8, 90.1. IR (thin film) ν max (cm-1): 3040 
(ArC-H), 1732 (C=O); HRMS (ESI): m/z calculated for 
C13H12O4: requires: 255.0633 for [M+Na]
+; found: 255.0667. 
 
Phenylmethylene dihexanoate 3e 
General procedure C was followed to afford the title 
compound (2.89 g, 9.02 mmol) as a clear oil in 96% yield. 
1H NMR (300 MHz, CDCl3) δ 7.71 (s, 1H, CHPh), 7.51 (qd, 
J = 3.7, 1.5 Hz, 2H, ArH), 7.40 (ddt, J = 4.2, 3.1, 1.6 Hz, 
3H, ArH), 2.37 (td, J = 7.4, 2.3 Hz, 4H, 2 x (C=O)CH2CH2), 
1.70 – 1.58 (m, 4H, 2 x (C=O)CH2CH2), 1.30 (dq, J = 7.2, 
3.7, 3.3 Hz, 8H, 2 x (C=O)CH2CH2), 0.94 – 0.82 (m, 6H, 2 x 
CH2CH2CH3). 
13C NMR (75 MHz, CDCl3) δ 171.8, 135.9, 
129.8, 128.7, 126.8, 89.6, 34.2, 31.3, 24.5, 22.4, 14.0. IR 
(thin film) ν max (cm-1): 2956 (ArC-H), 1752 (C=O); 
HRMS (ESI): m/z calculated for C19H28O4: requires: 
343.1885 for [M+Na]+; found: 343.1898. Analytical data in 
accordance with literature.29 
 
Phenylmethylene bis(2-phenylacetate) 3f 
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General procedure C was followed to afford the title 
compound (3.18 g, 8.84 mmol) as a clear oil in a 94% yield. 
1H NMR (250 MHz, CDCl3) δ 7.69 (s, 1H, CHPh), 7.43 – 
7.16 (m, 15H, ArH), 3.64 (s, 4H, 2 x CH2Ph). 
13C NMR (75 
MHz, CDCl3) δ 169.5, 135.3, 133.2, 129.9, 129.5, 129.4, 
128.7, 127.4, 126.7, 90.3, 41.1. IR (thin film) ν max (cm-1): 
3032, 2981 (ArC-H), 1759 (C=O); HRMS (ESI): m/z 




Phenylmethylene bis(2,2,2-trifluoroacetate) 3g 
Trifluoroacetic acid (0.035 mL, 0.47 mmol) was added in a 
dropwise manner to a solution of benzaldehyde (0.50 g, 4.7 
mmol) and trifluoroacetic anhydride (0.98 mL, 7.08 mmol) 
at rt. After 2 h the reaction was concentrated in vacuo to 
afford the title compound (1.4 g, 4.5 mmol) as a yellow oil 
in 95% yield. 1H NMR (300 MHz, CDCl3) δ 7.79 (s, 1H, 
ArH), 7.62 – 7.45 (m, 5H, ArH). 13C NMR (75 MHz, 
CDCl3) δ 155.3 (q, 
2JC-F = 44.7 Hz), 134.4, 131.8, 129.4, 
127.0, 114.1 (q, 1JC-F = 285.5 Hz), 93.8. IR (thin film) ν 
max (cm-1): 1809 (C=O).  
 
Benzyl propionate 13a 
General procedure D was followed to afford the title 
compound (0.154 g, 0.94 mmol) as a clear oil in 94% yield. 
1H NMR (300 MHz, CDCl3) δ 7.37 – 7.32 (m, 5H, ArH), 
5.12 (s, 2H, CH2Ph), 2.39 (q, J = 7.6 Hz, 2H, CH2CH3), 1.17 
(t, J = 7.6 Hz, 3H, CH2CH3). C NMR (75 MHz, CDCl3) δ 
174.5, 136.3, 128.7, 128.3, 126.8, 66.3, 27.8, 9.3. Analytical 
data in accordance with literature.30  
 
Benzyl benzoate 13b 
General procedure D was followed to afford the title 
compound (0.166 g, 0.78 mmol) as a clear oil in 78% yield. 
1H NMR (300 MHz, CDCl3) δ 8.11 – 8.07 (m, 2H, ArH), 
7.60 – 7.48 (m, 1H, ArH), 7.54 – 7.35 (m, 7H, ArH), 5.38 (s, 
2H, CH2Ph). 
13C NMR (75 MHz, CDCl3) δ 166.6, 136.2, 
133.2, 130.3, 129.8, 128.7, 128.5, 128.4, 128.3, 66.8. 
Analytical data in accordance with literature.30  
 
Benzyl acrylate 13c 
General procedure D was followed to afford the title 
compound (0.131 g, 0.81 mmol) as a clear oil in 81% yield. 
1H NMR (300 MHz, CDCl3) δ 7.39 – 7.32 (m, 5H, ArH), 
6.45 (dd, J = 17.3, 1.4 Hz, 1H, CH=CHaHb), 6.17 (dd, J = 
17.3, 10.4 Hz, 1H, CH=CHaHb), 5.85 (dd, J = 10.4, 1.4 Hz, 
1H, CH=CHaHb), 5.21 (s, 2H, CH2Ph). 
13C NMR (75 MHz, 
CDCl3) δ 166.2, 136.0, 131.2, 128.7, 128.5, 128.4, 128.4, 
66.5. Analytical data in accordance with literature.30  
 
Benzyl hexanoate 13d 
General procedure D was followed to afford the title 
compound (0.144 g, 0.70 mmol) as a clear oil in 70% yield. 
1H NMR (300 MHz, CDCl3) δ 7.37 – 7.32 (m, 5H, ArH), 
5.12 (s, 2H, CH2Ph), 2.37 (t, J = 7.5 Hz, 2H, 
(C=O)CH2CH2CH2CH2CH3), 1.71 – 1.61 (m, 2H, 
(C=O)CH2CH2CH2CH2CH3), 1.31 (dq, J = 7.5, 3.8, 3.2 Hz, 
4H, (C=O)CH2CH2CH2CH2CH3), 0.91 – 0.87 (m, 3H, 
(C=O)CH2CH2CH2CH2CH3). 
13C NMR (75 MHz, CDCl3) δ 
173.8, 136.3, 128.7, 128.3, 126.8, 66.2, 34.4, 31.4, 24.8, 
22.4, 14.0. Analytical data in accordance with literature.31  
 
Benzyl 2-phenylacetate 13e 
General procedure D was followed to afford the title 
compound (0.140 g, 0.62 mmol) as a clear oil in 62% yield. 
1H NMR (300 MHz, CDCl3) δ 7.40 – 7.28 (m, 10H, ArH), 
5.15 (s, 2H, PhCH2O), 3.68 (s, 2H, (C=O)CH2Ph). 
13C NMR 
(75 MHz, CDCl3) δ 171.5, 136.0, 134.0, 129.4, 128.7, 128.7, 
128.3, 128.2, 127.2, 66.7, 41.5. Analytical data in 
accordance with literature.31  
 
Benzyl 2,2,2-trifluoroacetate 13f 
Benzyl alcohol (0.108 g, 1.0 mmol) was added to 
phenylmethylene bis(2,2,2-trifluoroacetate) (0.474 g, 1.5 
mmol) and K2CO3 (2.0 mmol, 0.270 g) and the reaction 
stirred at rt for 1 h. The crude reaction mixture was then 
purified by column chromatography to give the title 
compound (0.181 g, 0.89 mmol) as a clear oil in 89% yield; 
1H NMR (300 MHz, CDCl3) δ 7.40 (s, 5H), 5.36 (s, 2H). 
13C 
NMR (75 MHz, CDCl3) δ 157.5 (q, 
2JC-F = 42.5 Hz), 133.4, 
129.4, 129.0, 128.8, 114.6 (q, 1JC-F = 285.8 Hz), 69.7. 
Analytical data in accordance with literature.32  
 
Acetoxy(phenyl)methyl pivalate 4a 
General procedure E was followed to afford the title 
compound (0.82 g, 3.30 mmol) as a clear oil in 75% yield. 
1H NMR (300 MHz, CDCl3)) δ 7.66 (s, 1H, OCHO), 7.53 – 
7.49 (m, 2H, ArH), 7.42 – 7.39 (m, 3H, ArH), 2.12 (s, 3H, 
C(O)CH3), 1.23 (s, 9H, C(O)C(CH3)3). 
13C NMR (75 MHz, 
CDCl3)) δ 176.4, 169.1, 135.8, 129.7, 128.7, 126.7, 89.9, 
39.0, 27.0, 21.1. 
 
Phenyl(2-phenylacetoxy)methyl pivalate 4b 
General procedure E was followed to afford the title 
compound (1.20 g, 3.69 mmol) as a clear oil in 84% yield. 
1H NMR (300 MHz, CDCl3) δ 7.68 (s, 1H, OCHO), 7.47 – 
7.43 (m, 2H, ArH), 7.41 – 7.38 (m, 3H, ArH), 7.31 – 7.26 
(m, 5H, ArH), 3.68 (s, 2H, CH2Ph), 1.17 (s, 9H, C(CH3)3). 
13C NMR (75 MHz, CDCl3) δ 176.3, 169.6, 135.7, 133.4, 
129.7, 129.4, 128.7, 128.7, 127.4, 126.6, 90.0, 41.3, 38.9, 
27.0. I R (thin film) ν max (cm-1): 2995, 2983 (ArC-H), 
1769, 1756 (C=O); HRMS (ESI): m/z calculated for 
C20H22O4: requires: 349.1410 for [M+Na]
+; found: 349.1473. 
 
Phenyl(propionyloxy)methyl pivalate 4c 
General procedure E was followed to afford the title 
compound (0.95 g, 3.62 mmol) as a clear oil in 82% yield.1H 
NMR (300 MHz, CDCl3) δ 7.68 (s, 1H, OCHO), 7.53 – 7.49 
(m, 2H, ArH), 7.42 – 7.38 (m, 3H, ArH), 2.40 (qd, J = 7.5, 
3.0 Hz, 2H, CH2CH3), 1.23 (s, 9H, C(CH3)3), 1.16 (t, J = 7.5 
Hz, 3H, CH2CH3).
 13C NMR (75 MHz, CDCl3) δ 176.4, 
172.5, 135.9, 129.7, 128.7, 126.7, 89.8, 39.0, 27.6, 27.0, 9.0. 
IR (thin film) ν max (cm-1): 2978 (ArC-H), 1754, 1750 
(C=O); HRMS (ESI): m/z calculated for C15H20O4: requires: 
287.1254 for [M+Na]+; found: 287.1268. 
 
Phenyl(pivaloyloxy)methyl acrylate 4d 
Tetrahedron 10 
General procedure E was followed to afford the title 
compound (0.92 g, 3.52 mmol) as a clear oil in 80% yield. 
1H NMR (300 MHz, CDCl3) δ 7.75 (s, 1H, OCHO), 7.56 – 
7.51 (m, 2H, ArH), 7.45 – 7.40 (m, 3H, ArH), 6.50 (dd, J = 
17.3, 1.4 Hz, 1H, CH=CHaHb), 6.15 (dd, J = 17.3, 10.4 Hz, 
1H, CH=CHaHb), 5.92 (dd, J = 10.4, 1.4 Hz, 1H, 
CH=CHaHb), 1.23 (s, 9H, C(CH3)3). 
13C NMR (75 MHz, 
CDCl3) δ 176.4, 164.1, 135.8, 132.6, 129.8, 128.7, 127.7, 
126.7, 90.0, 39.0, 27.0. IR (thin film) ν max (cm-1): 2975, 
2875 (ArC-H), 1744 (C=O); HRMS (ESI): m/z calculated 
for C15H18O4: requires: 285.1097 for [M+Na]
+; found: 
285.1149 
Phenyl(2-phenylacetoxy)methyl furanoate 4e 
General procedure E was followed to afford the title 
compound (1.00 g, 3.31 mmol) as a clear oil in 74% yield. 
1H NMR (300 MHz, CDCl3) δ 7.88 (s, 1H, CHPh), 7.61 (dd, 
J = 1.8, 0.8 Hz, 1H, C(=O)COCHCHCH), 7.60 – 7.55 (m, 
2H, ArH), 7.49 – 7.37 (m, 3H, ArH), 7.29 – 7.22 (m, 1H, 
C(=O)COCHCHCH), 6.52 (dd, J = 3.5, 1.7 Hz, 1H, 
C(=O)COCHCHCH), 1.25 (s, 9H, C(CH3)3). 
13C NMR (75 
MHz, CDCl3) δ 176.3, 156.5, 147.1, 143.7 135.5, 129.7, 
128.7, 126.6, 119.3, 112.0, 90.0, 38.9, 26.9. IR (thin film) 
νmax (cm
-1): 2976, 2875 (ArC-H), 1769, 1741 (C=O); HRMS 
(ESI): m/z calculated for C17H18O5: requires: 325.1046 for 
[M+Na]+; found: 325.1099. 
 
Benzyl acetate 12a 
General procedure D was followed to afford the title 
compound (0.135 g, 0.90 mmol) as a clear oil in 90% yield.  
Analytical data was in accordance with 12a synthesized 
using general procedure B.  
 
Benzyl propionate 13a 
General procedure D was followed to afford the title 
compound (0.154 g, 0.94 mmol) as a clear oil in 94% yield. 
Analytical data was in accordance with 13a synthesized 




Geraniol propanoate 13g 
General procedure D was followed to afford the title 
compound (0.091g, 0.43 mmol) as a clear oil in 86% yield. 
1H NMR (300 MHz, CDCl3) δ 5.45 – 5.22 (m, 1H, -
OCH2CH=), 5.08 (q, J = 1.4 Hz, 1H, CH2CH=C(CH3)2), 
4.60 (d, 2H, -OCH2C=), 2.33 (q, J = 7.6 Hz, 2H, 
C(=O)CH2CH3), 2.17 – 1.97 (m, 4H. CH2CH2CH=C(CH3)2), 
1.72 – 1.69 (m, 3H, CH=C(CH3aCH3b)2), 1.68 (d, J = 1.3 Hz, 
3H, -OCH2CHC(CH3)), 1.59 (dd, J = 5.2, 0.9 Hz, 3H, 
CH=C(CH3aCH3b)2), 1.14 (t, J = 7.6 Hz, 3H, 
C(=O)CH2CH3). 
13C NMR (75 MHz, CDCl3) δ 174.6, 142.2, 
131.9, 123.8, 118.3, 61.3, 39.6, 27.6, 26.3, 25.7, 17.7, 16.5, 
9.2. Analytical data in accordance with literature.33  
  
Geranyl furanoate 13h 
General procedure D was followed to afford the title 
compound (0.1195g, 0.48 mmol) as a clear oil in 96% yield. 
1H NMR (300 MHz, CDCl3) δ 7.57 (dd, J = 1.8, 0.9 Hz, 1H, 
C(=O)COCH), 7.18 (dd, J = 3.5, 0.9 Hz, 1H, C(=O)CCH), 
6.50 (dd, J = 3.5, 1.7 Hz, 1H, C(=O)CCHCH), 5.44 (tq, J = 
7.1, 1.3 Hz, 1H, -OCH2CH=), 5.09 (tt, J = 5.0, 2.8 Hz, 1H, 
CH2CH2CH=), 4.87 – 4.78 (m, 2H, -OCH2), 2.16 – 1.99 (m, 
4H, CH2CH2CH=), 1.75 (d, J = 1.3 Hz, 3H, 
CH=C(CH3aCH3b)), 1.67 (d, J = 1.3 Hz, 3H, 
OCH2CH=C(CH3), 1.60 (d, J = 1.3 Hz, 3H, 
CH=C(CH3aCH3b)).
 13C NMR (75 MHz, CDCl3) δ 158.8, 
146.2, 142.9, 131.9, 123.7, 117.9, 117.8, 111.8, 61.9, 60.4, 
39.6, 26.3, 25.7, 17.7, 16.6. IR (thin film) νmax (cm
-1: 2916 
(ArC-H), 1716 (C=O); HRMS (ESI): m/z calculated for 
C15H20O3: requires: 271.1305 for [M+Na]
+; found: 271.1302. 
 
Perillyl propanoate 13i 
General procedure D was followed to afford the title 
compound (0.098g, 0.47 mmol) as a clear oil in 94% yield. 
1H NMR (300 MHz, CDCl3) δ 5.80 – 5.67 (m, 1H, 
OCH2C=CH), 4.70 (dp, J = 3.0, 1.3 Hz, 2H, C(CH3)=CH2), 
4.45 (d, J = 1.7 Hz, 2H, OCH2), 2.34 (q, J = 7.6 Hz, 2H, 
C(=O)CH2), 2.22 – 2.02 (m, 4H, CH2C(CH2)=CCH2), 2.01 – 
1.77 (m, 1H, CH2=C(CH3)CH), 1.72 (s, 3H, CH2=C(CH3)), 
1.47 (ddt, J = 12.7, 11.3, 8.5 Hz, 2H, CH2=C(CH3)CHCH2), 
1.13 (t, J = 7.6 Hz, 3H, C(=O)CH2CH3). 
13C NMR (75 MHz, 
CDCl3) δ 174.4, 149.6, 132.7, 125.6, 108.8, 68.3, 40.8, 30.5, 
27.6, 27.3, 26.4, 20.7, 9.2. IR (thin film) νmax (cm
-1: 2921 
(ArC-H), 1736 (C=O); HRMS (ESI): m/z calculated for 
C13H18O2: requires: 231.1398 for [M+Na]
+; found: 231.1348. 
 
Perillyl furanoate 13j 
General procedure D was followed to afford the title 
compound (0.1021g, 0.42 mmol) as a clear oil in 83% yield. 
1H NMR (300 MHz, CDCl3) δ 7.58 (dd, J = 1.7, 0.9 Hz, 1H, 
C(=O)COCH), 7.19 (dd, J = 3.5, 0.8 Hz, 1H, C(=O)CCH), 
6.51 (dd, J = 3.5, 1.8 Hz, 1H, C(=O)CCHCH), 5.84 (ddd, J 
= 5.1, 2.8, 1.4 Hz, 1H, OCH2C=CH), 4.75 – 4.71 (m, 2H, 
C(CH3)=CH2), 4.71 – 4.69 (m, 2H, OCH2), 2.25 – 2.09 (m, 
4H, CH2C(CH2)=CCH2), 2.08 – 1.96 (m, 1H, 
CH2=C(CH3)CH), 1.74 (t, J = 1.1 Hz, 3H, CH2=C(CH3)),), 
1.62 – 1.19 (m, 2H, CH2=C(CH3)CHCH2). 
13C NMR (75 
MHz, CDCl3) δ 158.7, 149.6, 146.3, 144.7, 132.3, 126.3, 
117.9, 111.8, 108.8, 68.8, 40.8, 30.5, 27.3, 26.4, 20.8. IR 
(thin film) νmax (cm
-1: 2922 (ArC-H), 1716 (C=O); HRMS 
(ESI): m/z calculated for C15H18O3: requires: 269.1148 for 
[M+Na]+; found: 269.1145. 
 
Citronellyl acrylate 13k 
General procedure D was followed to afford the title 
compound (0.0772g, 0.37 mmol) as a clear oil in 73% yield. 
1H NMR (300 MHz, CDCl3) δ 6.40 (dd, J = 17.3, 1.6 Hz, 
1H, C(=O)CH=CHaHb), 6.12 (dd, J = 17.3, 10.4 Hz, 1H, 
C(=O)CH=CHaHb), 5.82 (dd, J = 10.4, 1.6 Hz, 1H, 
C(=O)CH=CHaHb), 5.09 (dddd, J = 7.1, 5.7, 2.9, 1.4 Hz, 1H, 
-OCH2CH2CH(CH3)CH2CH2CH=C(CH3)2), 4.32 – 3.99 (m, 
2H, -OCH2), 1.99 (td, J = 15.2, 13.5, 6.0 Hz, 2H, 
CH2CH=C(CH3)2), 1.68 (q, J = 1.4 Hz, 3H, 
CH=C(CH3aCH3b), 1.60 (d, J = 1.3 Hz, 3H, 
CH=C(CH3aCH3b), 1.53 – 1.08 (m, 5H, CH2CH(CH3)CH2), 
0.93 (d, J = 6.4 Hz, 3H, CHCH3). 
13C NMR (75 MHz, 
CDCl3) δ 166.4, 131.4, 130.5, 128.6, 124.6, 63.1, 36.9, 35.4, 
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29.5, 25.8, 25.4, 19.4, 17.7. Analytical data in accordance 
with literature.34  
 
Citronellyl furanoate 13l 
General procedure D was followed to afford the title 
compound (0.075g, 0.41 mmol) as a clear oil in 90% yield. 
1H NMR (300 MHz, CDCl3) δ 7.58 (dd, J = 1.7, 0.9 Hz, 1H, 
C(=O)COCH), 7.16 (dd, J = 3.5, 0.9 Hz, 1H, C(=O)CCH), 
6.51 (dd, J = 3.5, 1.8 Hz, 1H, C(=O)CCHCH), 5.09 (tt, J = 
7.1, 1.5 Hz, 1H, CH2CH=C(CH3)2), 4.45 – 4.24 (m, 2H, 
C(=O)COCH2), 2.08 – 1.90 (m, 2H, CH2CH=C(CH3)2), 1.67 
(q, J = 1.3 Hz, 3H, CH=C(CH3aCH3b)), 1.60 (d, J = 1.2 Hz, 
3H, CH=C(CH3aCH3b)), 1.56 (s, 2H, C(=O)COCH2CH2), 
1.46 – 1.31 (m, 2H, CH2CH2CH=C(CH3)2), 1.30 – 1.14 (m, 
1H, -OCH2CH2CH(CH3)), 0.95 (d, J = 6.4 Hz, 3H, -
OCH2CH2CH(CH3),). 
13C NMR (75 MHz, CDCl3) δ 158.9, 
146.2, 144.9, 131.4, 124.5, 117.7, 111.8, 63.6, 36.9, 35.5, 
29.5, 25.7, 25.4, 19.5, 17.7. IR (thin film) νmax (cm
-1): 2970, 
2926 (ArC-H), 1736 (C=O); HRMS (ESI): m/z calculated 




(S)-methyl 2-acetamido-3-hydroxypropanoate 16 
Et3N (0.42 mL, 3.21 mmol) was added in a dropwise manner 
to (S)-Serine methyl ester hydrochloride salt (0.5 g, 3.21 
mmol) suspended in acetone (3 mL). The reaction mixture 
was stirred for 10 min and then filtered through a Celite® 
pad. The filtrate was concentrated in vacuo to give (S)-serine 
methyl ester which was used without further purification. 
(S)-Serine methyl ester (1.0 mmol) was added to 
phenylmethylene diacetate 3a (0.291 g, 1.5 mmol) and 
NaHCO3 (0.168 g, 2.0 mmol) and EtOAc (2 mL) and the 
reaction was stirred at 60 °C for 16 h, followed by 
chromatographic purification to afford the title compound 
(0.428 g, 2.56 mmol) as a brown oil in 83% yield. [α]D
20 = -
9.5, c = 2.0, MeOH (Lit14a [α]D
25 -10.1 (c 1.9, MeOH)); 1H 
NMR (500 MHz, CDCl3) δ 6.52 (s, 1H, NH), 4.67 (dt, J = 
7.3, 3.6 Hz, 1H, CHNH), 4.01 – 3.89 (m, 2H, CH2OH), 3.79 
(s, 3H, OCH3), 2.81 (s, 1H, OH), 2.07 (s, 3H, (C=O)CH3), 
13C NMR (126 MHz, CDCl3) δ 171.1, 170.8, 63.6, 54.9, 
52.9, 23.3. IR (thin film) ν max (cm-1): 3291 ((C=O)NH and 
OH), 1738 (C=O ester), 1648 (C=O amide); HRMS (ESI): 
m/z calculated for C6H11NO4: requires: 162.0766 for 
[M+H]+; found: 162.0788. Analytical data in accordance 
with literature.14 
 
(S)-methyl 2-acetamido-3-(formyloxy)propanoate 17 
General procedure A was followed to afford the title 
compound (0.377 g, 2.0 mmol) as a white solid in 78% 
yield. m.p. 95-97 °C, [α]D
20 = -56.0, c 1.0, CHCl3. 
1H NMR 
(300 MHz, CDCl3) δ 8.03 (q, J = 0.9 Hz, 1H, (C=O)H), 6.28 
(s, 1H, NH), 4.90 (dt, J = 7.1, 3.3 Hz, 1H, CHNH), 4.60 – 
4.45 (m, 2H, CH2O(C=O)H), 3.80 (s, 3H, OCH3), 2.06 (s, 
3H, (C=O)CH3). 
13C NMR (75 MHz, CDCl3) δ 170.0, 169.9, 
160.3, 63.6, 53.2, 51.6, 23.2. IR (thin film) ν max (cm-1): 
3292 ((C=O)NH), 1727, 1713, 1703 (C=O); HRMS (ESI): 
m/z calculated for C7H11NO5: requires: 190.0715 for 
[M+H]+; found: 190.0739. 
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